Today: 11 June 2026
Browse Category

Dividend Investing 8 December 2025 - 11 December 2025

Best UK Stocks to Buy Now (11 December 2025): 9 FTSE Shares for 2026 Growth, Income and Value

Best UK Stocks to Buy Now (11 December 2025): 9 FTSE Shares for 2026 Growth, Income and Value

The FTSE 100 hovered near record highs around 9,600–9,700 on December 11, 2025, after a strong rally led by banks, energy, miners, and defense stocks. Despite a 22.8% total return for the year, UK equities remain valued below global peers at about 12.5 times 2026 earnings. Inflation has eased to the mid-3% range, and the Bank of England’s base rate sits near 4% after earlier cuts. Investors remain cautious as European shares dip and tech stocks weaken.
11 December 2025
··
Verizon Communications Inc. (VZ) Stock on December 10, 2025: Price, Dividend Yield, Layoffs and Wall Street Forecasts

Verizon Communications Inc. (VZ) Stock on December 10, 2025: Price, Dividend Yield, Layoffs and Wall Street Forecasts

Verizon shares traded near $40 Wednesday after a 2.8% drop Tuesday on heavy volume. Morgan Stanley cut its price target to $47, citing a tougher telecom outlook. Institutional investors showed mixed moves, with Intact Investment Management trimming its stake and BCS Private Wealth opening a new position. Verizon’s dividend yield remains near 7%, among the highest in the Dow.
10 December 2025
··
Medical Properties Trust (MPW) Stock in December 2025: Dividend Hike, Heavy Short Interest and a High‑Risk Turnaround

Medical Properties Trust (MPW) Stock in December 2025: Dividend Hike, Heavy Short Interest and a High‑Risk Turnaround

Medical Properties Trust shares trade at $5.54 with a market cap of $3.3 billion and a forward dividend yield above 6% after a 12% dividend hike announced November 17. The hospital REIT’s stock has rebounded about 40% year-to-date but remains among the most shorted in the U.S. MPW owns nearly 400 hospital properties across nine countries. Five-year total return is still down roughly 60% from pre-2022 levels.
10 December 2025
·
Merck (MRK) Stock on December 10, 2025: Price Action, Dividend Catalyst, Analyst Targets and the Keytruda Question

Merck (MRK) Stock on December 10, 2025: Price Action, Dividend Catalyst, Analyst Targets and the Keytruda Question

Merck shares traded near $97.31 Wednesday afternoon, up slightly after Tuesday’s 2% drop. Volume topped 3.2 million as investors tracked dividend moves and new analyst upgrades. The stock remains about 25% below 2024 highs despite a 41% six-month rally. Signs of rising competition to Keytruda and looming patent pressures weighed on sentiment.
10 December 2025
··
Campbell’s (CPB) Stock Hits 52‑Week Lows After Q1 2026 Earnings and Fitch Downgrade – Is the 5.5% Dividend Worth the Risk?

Campbell’s (CPB) Stock Hits 52‑Week Lows After Q1 2026 Earnings and Fitch Downgrade – Is the 5.5% Dividend Worth the Risk?

Campbell’s shares hit a new 52-week low of $28.13 on December 10, dropping further after a post-earnings slide. Fitch downgraded the company’s credit rating to BBB- with a Stable outlook, citing high leverage and weak trends. Q1 fiscal 2026 results showed sales down 3% and adjusted EPS down 13%, but both slightly beat analyst estimates. Margins fell as tariffs and inflation drove costs higher.
10 December 2025
···
Best UK Stocks to Buy Now (10 December 2025): 8 FTSE Shares for Growth, Income & Recovery

Best UK Stocks to Buy Now (10 December 2025): 8 FTSE Shares for Growth, Income & Recovery

The FTSE 100 rose yesterday as gains in BAE Systems and Rolls-Royce offset losses in British American Tobacco. Investors are positioning for possible rate cuts in 2026, with UK inflation down to 3.6% in October. The Bank of England expects the upcoming budget to further reduce inflation and says banks remain resilient. FTSE 100 companies are set to repurchase about £56.6bn in stock this year.
10 December 2025
······
Singtel (SGX: Z74) Stock on 10 December 2025: Price, Dividend Payout, Buyback Firepower and 2026 Outlook

Singtel (SGX: Z74) Stock on 10 December 2025: Price, Dividend Payout, Buyback Firepower and 2026 Outlook

Singtel shares traded near record highs at S$4.58 on December 10, after a year-long rally of about 50–55%. The company posted a 14% rise in underlying net profit to S$1.35 billion for H1 FY26 and raised full-year guidance. Its Australian unit Optus faces fallout from network failures and a record court fine. Singtel’s dividend yield is close to 4%.
10 December 2025
···
Macquarie Group (ASX: MQG) Stock Outlook on 10 December 2025: Qube Bid, Dividend Payout and 2026 Forecasts

Macquarie Group (ASX: MQG) Stock Outlook on 10 December 2025: Qube Bid, Dividend Payout and 2026 Forecasts

Macquarie Group shares traded at A$194.7 in Sydney on 10 December 2025, flat over the past week and down nearly 12% year-to-date. The company reported a first-half net profit of A$1.655 billion, up 3% year-on-year but below market expectations. A major A$11.6 billion takeover proposal remains under review. An increased interim dividend is due next week.
10 December 2025
··
Singtel Stock on 9 December 2025: Price, Dividend Payout, Outlook and Key Risks for SGX: Z74

Singtel Stock on 9 December 2025: Price, Dividend Payout, Outlook and Key Risks for SGX: Z74

Singtel traded at S$4.58 on 9 December 2025, up 0.4%, after hitting an all-time high of S$4.92 in November. The company paid an interim dividend of 8.2 cents per share today. Underlying net profit for H1 FY26 rose 14% to S$1.35 billion, while reported net profit surged to S$3.4 billion. The stock has pulled back about 4–5% over the last 10 sessions.
9 December 2025
··
DBS Group Holdings (SGX: D05) Stock Outlook 2026: Share Price, Dividend Yield and Forecast After Record Q3 2025

DBS Group Holdings (SGX: D05) Stock Outlook 2026: Share Price, Dividend Yield and Forecast After Record Q3 2025

DBS Group Holdings traded at S$54.04 on 9 December 2025, near its all-time high and up 24% from a year earlier. The bank reported record Q3 total income of S$5.93 billion and profit before tax of S$3.48 billion, though net profit dipped slightly. Market capitalization stands at about S$154 billion. Management and analysts warn net interest margins may soften in 2026.
9 December 2025
·
Chevron (CVX) Stock on December 8, 2025: Price, Dividend Yield, Nigeria Push and Gorgon LNG Expansion Shape 2026 Outlook

Chevron (CVX) Stock on December 8, 2025: Price, Dividend Yield, Nigeria Push and Gorgon LNG Expansion Shape 2026 Outlook

Chevron shares traded near $150 on December 8, 2025, giving the company a $302 billion market cap and a 4.56% dividend yield. The stock is down about 5–6% over the past year as oil prices slipped to $63 per barrel for Brent. Technical indicators show a “sell” rating. Chevron’s Q3 earnings reached $3.5 billion.
8 December 2025
···
British American Tobacco Stock in December 2025: ITC Hotels Sale, Buybacks and Dividend Outlook for BTI & BATS Investors

British American Tobacco Stock in December 2025: ITC Hotels Sale, Buybacks and Dividend Outlook for BTI & BATS Investors

British American Tobacco sold a 9% stake in ITC Hotels on 5 December 2025, raising about $420 million and cutting its holding to 6.3%. BAT shares closed at £42.83 in London, up over 40% year-on-year and near a 52-week high, with the ADR near $57 in New York. The company plans to use proceeds to reduce debt, targeting a leverage ratio of 2.0–2.5x by end-2026.
8 December 2025
····
Vodafone Group (VOD) Stock Outlook 2026: Dividend Revival, Safaricom Deal and Split Analyst Views

Vodafone Group (VOD) Stock Outlook 2026: Dividend Revival, Safaricom Deal and Split Analyst Views

Vodafone shares have rebounded 44% year-on-year in London, closing near 93.9p, with the U.S. ADR at $12.47, close to its 52-week high. H1 FY26 results showed revenue up 7.3% to €19.6bn, but operating profit fell 9.2% to €2.2bn. The company raised full-year guidance and increased its dividend for the first time in years. Credit agencies remain cautious despite the recovery.
8 December 2025
··
United Overseas Bank Limited (U11.SI) Stock: Can a 6.6% Dividend Yield Outweigh Margin and Credit Risks in 2026?

United Overseas Bank Limited (U11.SI) Stock: Can a 6.6% Dividend Yield Outweigh Margin and Credit Risks in 2026?

UOB shares traded at S$34.5 on 8 December 2025, down about 5% year-to-date. Q3 net profit plunged 72% to S$443 million after S$1.36 billion in credit provisions, mainly tied to commercial property in Hong Kong and the US. The bank maintains a 6.6% dividend yield. Analysts rate the stock “Neutral” with target prices near current levels.
8 December 2025
··
Exxon Mobil (XOM) Stock Before the Market Opens on December 8, 2025: Price, Dividend Safety, Analyst Targets and Key Catalysts

Exxon Mobil (XOM) Stock Before the Market Opens on December 8, 2025: Price, Dividend Safety, Analyst Targets and Key Catalysts

Exxon Mobil closed at $116.54 on December 5, down 0.51%, with after-hours trading lifting shares to $116.94. The stock remains near its 52-week high of $120.81, supported by firm oil prices and a 43-year dividend growth streak. Wall Street sees 8–10% upside over the next year, but forecasts lower crude prices in 2026. Exxon’s Corporate Plan Update webcast is set for December 9.
8 December 2025
··
1 … 3 4 5 6 7 … 10

Stock Market Today

  • US Stocks Rise on AI Gains as Oil Prices Steady Amid Iran War Concerns
    June 11, 2026, 10:56 AM EDT. US stock indices climbed on Thursday, led by artificial intelligence (AI) stocks driving gains in chipmakers like Marvell Technology (+4.3%) and Intel (+10.4%). The S&P 500 rose 0.6%, with the Nasdaq up 0.8% and the Dow gaining 0.7%. Despite escalating tensions in the Iran war, oil prices held steady, with Brent crude easing 1.1% to $92.08 per barrel and U.S. crude down 0.6% to $89.52. The market showed resilience despite concerns over inflation pressures fueled by higher wholesale prices and renewed geopolitical risks. Oracle fell 10.3% after announcing substantial planned borrowing and equity sales to fund AI investments, reflecting investor caution on aggressive spending amidst uncertainty.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Go toTop